Rumeysa Ozturk, a Tufts University medical graduate student from Turkey whose charges were dropped after DHS detained her for allegedly "[engaging] in activities in support of Hamas," has ...

Last year, Yale University President Maurie McInnis formed a committee of Yale faculty members to "undertake a project of thorough self-examination." She wanted to know: Why is the public losing trust ...

GoodRx announced Wednesday that eligible Wegovy users will be able to access the newly approved higher 7.2-mg dose injection for $399 per month. The platform is giving eligible self-pay patients ...

You’re reading Red Tape, a newsletter on the consequences of overregulation. Click here to get it in your inbox. Meghan Portfolio is manager of research and analysis at the Yankee Institute.

If you could inject yourself with a substance that purports to make you tanner, fitter and healthier, would you? Many people are saying “yes.” Online, social media influencers tout vials of substances ...

AI assistants are rapidly becoming a core part of workplace productivity, but new research suggests they may also introduce a previously overlooked phishing vector. Permiso researchers found that ...

Wednesday marks one month since House Republicans took a bold stand for the soul of our democracy by passing the SAVE America Act. This common-sense legislation requires proof of citizenship to vote ...

Let’s pretend there’s a giant switch we could flip that would shut down all the injection wells in Southeast Ohio. Environmental activists will, of course, jump for joy. Susan Vessels might even calm ...

If you take Zepbound, a doctor or another healthcare professional will likely give you the first dose in their office. Then, they’ll show you or someone else how to inject Zepbound at home. You can ...

Are the argument, evidence, structure and style working in your scholarly book? Or are you stuck in a cycle of directionless tinkering? Find out why developmental editing is crucial to addressing ...

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...